NCT00001615View on ClinicalTrials.gov

Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration

PHASE1CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

July 31, 1997

Study Completion Date

May 31, 2000

Conditions

Choroidal NeovascularizationMacular Degeneration

Interventions

DRUG

Corticosteroid

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH